Thailand Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Thailand Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “Thailand Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Thailand's pharmaceutical industry is Southeast Asia's second-largest pharmaceutical market, after Indonesia. In 2013, Thailand's pharmaceutical market was valued at $4.7 billion in terms of production value. In 2019, it increased at a Compound Annual Growth Rate (CAGR) of 4% to $5.9 billion. By 2026, the market value is forecast to rise to $7.7 billion. In 2018, the medical devices market of Thailand generated revenue of $6.3 billion. It is expected to reach $6.5 billion in 2025 from 2018 at a CAGR of 0.4%. Thailand's government established a 10-year strategy (2016–25) named “Thailand, a Hub of Wellness and Medical Services” to maximize the use of all human and natural resources while also increasing the income levels of various classes of people, resulting in a significant increase in the quality of life of Thai residents. The government organized the strategy into four major segments namely wellness hub, medical services hub, academic medical center, and health products in order to achieve the goal.

Scope

• The report provides information on the healthcare, regulatory, and reimbursement landscape in Thailand, and includes:
• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, Novartis, GSK, and Roche.
• Profiles and SWOT analyses of the major players in the medical device market: Fresenius, Abbott, GE Healthcare, Hoya, and Nipro.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Thailand healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving Thailand healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Thailand healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership